Nucleoside transport and its significance for anticancer drug resistance

被引：132
|
作者：
Mackey, JR
Baldwin, SA
Young, JD
Cass, CE
机构：
[1] Univ Alberta, Dept Oncol, Edmonton, AB T6G 1Z2, Canada
[2] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada
[3] Univ Leeds, Sch Biochem & Mol Biol, Leeds LS2 9JT, W Yorkshire, England
[4] Univ Alberta, Dept Physiol, Edmonton, AB T6G 1Z2, Canada
来源：
DRUG RESISTANCE UPDATES | 1998年 / 1卷 / 05期
基金：
英国医学研究理事会; 英国惠康基金;
关键词：
D O I：
10.1016/S1368-7646(98)80047-2
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
This article discusses the role of nucleoside transport processes in the cytotoxicity of clinically important anticancer nucleosides. This article summarizes recent advances in the molecular biology of nucleoside transport proteins, review the current state of knowledge of the transportability of therapeutically useful anticancer nucleosides, and provide an overview of the role of nucleoside transport deficiency as a mechanism of resistance to nucleoside cytotoxicity are summarized. Several strategies for utilization of nucleoside transport processes to improve the therapeutic index of anticancer therapies, including the use of nucleoside-transport inhibitors to modulate toxicity of both nucleoside and nonnucleoside antimetabolite drugs are also presented.
引用
收藏
页码：310 / 324
页数：15
相关论文
共 50 条
  • [1] Nucleoside-based anticancer drugs: Mechanism of action and drug resistance
    Hruba, Lenka
    Das, Viswanath
    Hajduch, Marian
    Dzubak, Petr
    BIOCHEMICAL PHARMACOLOGY, 2023, 215
  • [2] Molecular mechanisms of nucleoside and nucleoside drug transport
    Young, JD
    Cheeseman, CI
    Mackey, JR
    Cass, CE
    Baldwin, SA
    GASTROINTESTINAL TRANSPORT, 2001, 50 : 329 - 378
  • [3] Efficient overcoming of drug resistance to anticancer nucleoside analogs by nanodelivery of active phosphorylated drugs
    Galmarini, Carlos M.
    Warren, Galya
    Senanayake, Madapathage T.
    Vinogradov, Serguei V.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2010, 395 (1-2) : 281 - 289
  • [4] Nucleoside anticancer drugs: the role of nucleoside transporters in resistance to cancer chemotherapy
    Vijaya L Damaraju
    Sambasivarao Damaraju
    James D Young
    Stephen A Baldwin
    John Mackey
    Michael B Sawyer
    Carol E Cass
    Oncogene, 2003, 22 : 7524 - 7536
  • [5] Nucleoside anticancer drugs: the role of nucleoside transporters in resistance to cancer chemotherapy
    Damaraju, VL
    Damaraju, S
    Young, JD
    Baldwin, SA
    Mackey, J
    Sawyer, MB
    Cass, CE
    ONCOGENE, 2003, 22 (47) : 7524 - 7536
  • [6] NUCLEOSIDE SALVAGE AND RESISTANCE TO ANTIMETABOLITE ANTICANCER AGENTS
    FOX, M
    BOYLE, JM
    KINSELLA, AR
    BRITISH JOURNAL OF CANCER, 1991, 64 (03) : 428 - 436
  • [7] Anticancer drug resistance
    Benard, J
    Rixe, O
    PRESSE MEDICALE, 1996, 25 (35): : 1724 - 1730
  • [8] Anticancer drug candidate against drug resistance in leukemia and its mechanisms of action
    Xing, Chengguo
    Hermanson, David
    Das, Sonia
    Bleeker, Nicholas
    Li, Yunfang
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [9] MRP1 and its role in anticancer drug resistance
    Lu, Jamie F.
    Pokharel, Deep
    Bebawy, Mary
    DRUG METABOLISM REVIEWS, 2015, 47 (04) : 406 - 419
  • [10] Nucleoside transport and resistance to genotoxic stress
    Robinson, Matthew
    Repalli, Jayanthi
    Jones, Larry
    Wyatt, Michael
    Berger, Sondra
    CANCER RESEARCH, 2009, 69
12345